Aker Biomarine Withdraws Patent Lawsuit Against Rimfrost
21 Apr 2017 --- Aker Biomarine has voluntarily withdrawn its complaint at the International Trade Commission (ITC), alleging that krill manufacturer Rimfrost had violated several of its patents. Rimfrost owner, Stig Remøy welcomed the news and claimed that it shows that his company “has been right all along.” “Aker Biomarine has no case, because you cannot patent nature itself,” he said. Rimfrost has said that Aker Biomarine’s patent dispute with Rimfrost has had negative effects on the global krill market. “We are observing that Aker Biomarine adopts harsh methods in an attempt to usurp a global krill monopoly,” Remøy says. “This will not succeed, and cannot be accepted by us. When krill licenses were allocated in 2007, Norwegian authorities made it clear that it is in the nation's interest that licenses are distributed to multiple players.” Remøy adds that as the ITC case closes, new market opportunities for Rimfrost are emerging. “Rimfrost’s ambitions with krill are extensive,” Remøy says, “Our considerable krill oil capacities allow us to market worldwide.” “In addition,” he says, “krill has major potential in the aquaculture market. Our technology increases growth and improves health for farmed salmon.” Explaining the decision to drop the lawsuit, Katrin Berntsen, the Director Communication at Aker BioMarine told NutritionInsight that, “Since the ITC investigation started, Olympic Holding and Emerald Fisheries have gone bankrupt and their “Juvel” krill harvesting vessel has been seized by creditors.” “Last week, we settled the patent dispute with Avoca. Considering these developments, Aker BioMarine has asked the ITC to discontinue its investigation.” “Aker BioMarine will direct its resources used to maintain the ITC investigation to continue to pursue its claim for patent infringement and damages from Rimfrost and Bioriginal in the pending District Court case in Delaware.” Berntsen added that, “The omega-3 market where we compete with our Superba ingredient has been soft.” “In this competitive market, in order to drive growth, we have invested in market innovation and science that can drive demand in new market segments.” To contact our editorial team please email us at editorial@cnsmedia.com
Related ArticlesNutrition & Health News UK: Boots urged to ditch krill products amid Greenpeace concerns17 Apr 2018 --- UK pharmacy-led health and beauty chain Boots has come under fire for selling krill products which threaten Antarctic wildlife with Greenpeace claiming stocks are being plundered for krill oil and omega 3 tablets. Nutrition & Health News Platform for innovation: A hearty applause for omega fatty acids14 Mar 2018 --- It has long been established that healthy fats are an important attribute of a healthy diet. Today, consumers are armed with a far more sophisticated knowledge of the range of goodies and baddies within the “fat” world. We have seen a rapid departure from the days when low-fat products reigned supreme, with consumers turning back to fat as a source of health. Healthy front-runners are the omega 3 fatty acids, with their prevalent claims of cardiovascular health benefits Nutrition & Health News “License to Krill”: Greenpeace investigation questions krill fisheries' sustainability14 Mar 2018 --- A five-year Greenpeace investigation has pitted strong accusations against the krill fishing industry, stating that the rising level of krill fishing poses environmental risks ranging from disrupting the Antarctic food chain, to contaminating a pristine area with vessel fuel spills and fires. Nutrition & Health News Omega 3: A rich source of health benefits and NPD opportunities11 Sep 2017 --- Omega 3’s benefits keep making the news in the world of nutrition, with the fatty acids’ tight connection to the healthy aging trend just one of the reasons why omega 3 continues to be on the tips of everyone’s tongues. Business News Rimfrost’s petition success could put Aker’s US krill oil patents back in play24 Aug 2017 --- Norwegian biotechnology company Rimfrost AS, supplier Rimfrost Sublime krill oil, has announced that the US Patent and Trademark Office has issued four decisions finding that a reasonable likelihood exists that every claim of two patents owned to Aker Biomarine Antarctic AS are unpatentable. “We are gratified that the US Patent Office has instituted Inter Partes Review proceedings of the Aker patents,” says Rimfrost owner Stig Remøy. “It confirms Rimfrost’s longstanding belief that the Aker patents are not valid and should have never been issued in the first place.” More Articles |
.jpg)
